PPC China Corp.

PPC Group (PPC China Corp) is a premier full-service Contract Research Organization (CRO) headquartered in Shanghai, specializing in clinical development services across the Asia-Pacific region. Since its inception in 1997, the company has established a robust infrastructure for Phase I-IV clinical trials, bioanalytical laboratory services, and site management organization (SMO) operations. In 2021, PPC merged with dMed Biopharmaceutical to form dMed-PPC, a move that combined PPC's extensive regional execution capabilities with dMed's global clinical strategy and regulatory expertise. The company plays a critical role in helping international pharmaceutical firms navigate the Chinese market and assisting Chinese biotech companies in expanding their clinical programs globally. With a workforce of over 2,000 professionals, the organization provides end-to-end solutions from early-stage development to post-marketing studies.